企業プロフィール
Stoke Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- STOK
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
32.29 USD (+2.83%)
終値
最終更新: 2026年8月21日
1.79B USD
時価総額
株価変動の要因
As of Aug 21, 2026, STOK closed up 2.83% at $32.29. No new same-company headline was identified in the current news window.
企業概要
事業概要
Stoke Therapeutics is a genetic-medicine company focused on RNA-based approaches for severe diseases such as epilepsy. Its platform is aimed at restoring protein expression in haploinsufficient conditions.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Stoke sits in specialty biotechnology.
ビジネスモデルの特徴
The company depends on clinical proof, RNA platform validation, and the ability to translate genetic medicine into real value.
バイオ業界での位置付け
Stoke is a high-beta genetic-medicine name whose valuation is closely tied to clinical progress.
今後のカタリスト
- Stoke Therapeutics's catalysts are zorevunersen in Dravet syndrome and its SYNGAP1 program. The next update matters because the company’s neuroscience story is still very focused.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。